Department of Endocrinology, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
The Third School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Front Endocrinol (Lausanne). 2023 Feb 27;14:1144834. doi: 10.3389/fendo.2023.1144834. eCollection 2023.
Clinical heterogeneity exists in overall obesity and abdominal obesity in terms of insulin secretion and sensitivity. Further, the impact of visceral fat (VF) on the first- and second-phase insulin secretion (FPIS and SPIS) is controversial. We aim to investigate insulin secretion and sensitivity in Chinese patients with T2DM according to different BMI and VF levels.
This study enrolled 300 participants. A dual bioelectrical impedance analyzer was used to assess the visceral and subcutaneous fat area (VFA and SFA). VF levels were categorized as normal or high, with the cutoff value of 100 cm. FPIS and SPIS were evaluated by arginine stimulation test and standardized steamed bread meal tolerance test, respectively. β-cell function (HOMA2-β), insulin resistance (HOMA2-IR), and Gutt's insulin sensitivity index (Gutt-ISI) were also calculated. Spearman's correlation analysis and multivariate linear regression analysis were adopted for statistical analysis.
Participants were categorized into four groups: normal weight-normal VF, normal weight-high VF, overweight/obese-normal VF and overweight/obese-high VF. Multivariate linear regression showed that both VFA and SFA were correlated with FPIS, HOMA2-IR and Gutt-ISI after controlling for gender and diabetes duration. After further adjustment for BMI and VFA, some associations of SFA with insulin secretion and sensitivity disappeared. After adjustment for gender, diabetes duration, BMI and SFA, VFA was positively correlated with FPIS, SPIS and HOMA2-IR. Subjects with overweight/obese-high VF were more likely to have higher FPIS, HOMA2-IR and lower Gutt-ISI (all < 0.05).
VF affects both FPIS and SPIS, and worsens insulin sensitivity independent of BMI and subcutaneous fat in Chinese patients with T2DM.
http://www.chictr.org.cn, identifier ChiCTR2200062884.
在胰岛素分泌和敏感性方面,总体肥胖和腹部肥胖存在临床异质性。此外,内脏脂肪(VF)对第一和第二时相胰岛素分泌(FPIS 和 SPIS)的影响存在争议。我们旨在根据不同的 BMI 和 VF 水平,研究中国 2 型糖尿病患者的胰岛素分泌和敏感性。
本研究纳入了 300 名参与者。使用双生物电阻抗分析仪评估内脏和皮下脂肪面积(VFA 和 SFA)。VF 水平分为正常或高,以 100cm 为截断值。通过精氨酸刺激试验和标准化馒头餐耐量试验分别评估 FPIS 和 SPIS。还计算了β细胞功能(HOMA2-β)、胰岛素抵抗(HOMA2-IR)和 Gut 胰岛素敏感性指数(Gutt-ISI)。采用 Spearman 相关分析和多元线性回归分析进行统计分析。
参与者被分为四组:正常体重-正常 VF、正常体重-高 VF、超重/肥胖-正常 VF 和超重/肥胖-高 VF。多元线性回归显示,在控制性别和糖尿病病程后,VFA 和 SFA 均与 FPIS、HOMA2-IR 和 Gutt-ISI 相关。进一步调整 BMI 和 VFA 后,SFA 与胰岛素分泌和敏感性的一些关联消失。在调整性别、糖尿病病程、BMI 和 SFA 后,VFA 与 FPIS、SPIS 和 HOMA2-IR 呈正相关。超重/肥胖-高 VF 组的 FPIS、HOMA2-IR 更高,Gutt-ISI 更低(均<0.05)。
VF 影响 FPIS 和 SPIS,且独立于 BMI 和皮下脂肪,加重中国 2 型糖尿病患者的胰岛素敏感性。
http://www.chictr.org.cn,标识符 ChiCTR2200062884。